Valenced action/inhibition learning in humans is modulated by a genetic variant linked to dopamine D2 receptor expression by Anni Richter et al.
ORIGINAL RESEARCH ARTICLE
published: 06 August 2014
doi: 10.3389/fnsys.2014.00140
Valenced action/inhibition learning in humans is modulated
by a genetic variant linked to dopamine D2 receptor
expression
Anni Richter1, Marc Guitart-Masip2,3, Adriana Barman1, Catherine Libeau1, Gusalija Behnisch1,
Sophia Czerney1, Denny Schanze4, Anne Assmann1, Marieke Klein1†, Emrah Düzel5,6,7,8,
Martin Zenker4, Constanze I. Seidenbecher1,8 and Björn H. Schott1,8,9,10*
1 Department of Neurochemistry and Molecular Biology, Department of Behavioral Neurology, Leibniz Institute for Neurobiology, Magdeburg, Germany
2 Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, UK
3 Ageing Research Centre, Karolinska Institute, Stockholm, Sweden
4 Institute of Human Genetics, Otto von Guericke University of Magdeburg, Magdeburg, Germany
5 Institute of Cognitive Neurology and Dementia Research, Otto von Guericke University Magdeburg, Magdeburg, Germany
6 Institute of Cognitive Neuroscience, University College London, London, UK
7 German Center for Neurodegenerative Diseases, Magdeburg, Germany
8 Center for Behavioral Brain Sciences, Otto von Guericke University of Magdeburg, Magdeburg, Germany
9 Department of Psychiatry, Charité University Hospital, Berlin, Germany
10 Department of Neurology, University of Magdeburg, Magdeburg, Germany
Edited by:
Daniela Laricchiuta, IRCCS Santa
Lucia Foundation, Italy
Reviewed by:
C. Nico Boehler, Ghent University,
Belgium
Alexander Strobel, Technische
Universitaet Dresden, Germany
*Correspondence:
Björn H. Schott, Leibniz Institute for
Neurobiology, Brenneckestr. 6,
39118 Magdeburg, Germany
e-mail: bschott@neuro2.
med.uni-magdeburg.de
†Present address:
Marieke Klein, Department of
Human Genetics, Donders Institute
for Brain, Cognition and Behaviour,
Radboud University Medical Centre,
Nijmegen, Netherlands
Motivational salience plays an important role in shaping human behavior, but recent
studies demonstrate that human performance is not uniformly improved by motivation.
Instead, action has been shown to dominate valence in motivated tasks, and it is
particularly difficult for humans to learn the inhibition of an action to obtain a reward,
but the neural mechanism behind this behavioral specificity is yet unclear. In all mammals,
including humans, the monoamine neurotransmitter dopamine is particularly important
in the neural manifestation of appetitively motivated behavior, and the human dopamine
system is subject to considerable genetic variability. The well-studied TaqIA restriction
fragment length polymorphism (rs1800497) has previously been shown to affect striatal
dopamine metabolism. In this study we investigated a potential effect of this genetic
variation on motivated action/inhibition learning. Two independent cohorts consisting of
87 and 95 healthy participants, respectively, were tested using the previously described
valenced go/no-go learning paradigm in which participants learned the reward-associated
no-go condition significantly worse than all other conditions. This effect was modulated
by the TaqIA polymorphism, with carriers of the A1 allele showing a diminished
learning-related performance enhancement in the rewarded no-go condition compared to
the A2 homozygotes. This result highlights a modulatory role for genetic variability of the
dopaminergic system in individual learning differences of action-valence interaction.
Keywords: dopamine D2 receptor, TaqIA, reward learning, motivated learning, action bias
INTRODUCTION
Efficient decision making requires an individual to select
responses that maximize reward and minimize punishment or
loss. Such motivated behavior involves two fundamental axes of
control, namely valence—spanning reward and punishment, and
action—spanning invigoration and inhibition. Previous studies
have shown that these two axes are not independent (Guitart-
Masip et al., 2012b, 2013; Cavanagh et al., 2013; Chowdhury et al.,
2013; for review see Guitart-Masip et al., 2014) and that deci-
sion making is not only influenced by an instrumental controller
that learns to optimize choices on the basis of their contingent
consequences, but also on a Pavlovian controller that generates
stereotyped, “hard-wired” behavioral responses to the occurrence
of motivationally salient outcomes or learned predictions of such
outcomes (Dickinson and Balleine, 2002; Guitart-Masip et al.,
2013). The presence of such “hard-wired” response patterns may
be an evolutionarily beneficial adaptation to an environment
world in which obtaining a reward typically requires some sort
of overt behavioral response (go to win) whereas avoiding a pun-
ishment rather requires an avoidance of those actions that may
lead to it (no-go to avoid losing). On the other hand, such a
response bias may also be a source of suboptimal behavior when
Pavlovian and instrumental controllers are in opposition (Breland
and Breland, 1961; Dayan et al., 2006; Boureau and Dayan, 2011).
In order to manipulate action and valence orthogonally,
Guitart-Masip et al. (2012b) designed a go/no-go learning task
that involves besides the commonly investigated conditions go to
win and no-go to avoid losing also the vice versa conditions where
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the participant needs to perform an action to avoid a punishment
(go to avoid losing) or to inhibit an action to obtain a reward (no-
go to win). Studies employing this task have repeatedly shown that
while active choices in rewarded conditions and passive choices in
punished conditions can be learned easily, it is significantly harder
to learn an approach behavior to avoid a punishment and yet even
more difficult to inhibit an action to obtain a reward. This asym-
metry indicates that signals that predict reward are prepotently
associated with behavioral activation, whereas signals that predict
punishment are intrinsically coupled to behavioral inhibition.
In search for neural mechanisms underlying this behav-
ioral asymmetry in the coupling between action and valence,
monoaminergic, particularly dopaminergic, neuromodulation is
a prime candidate (Gray and McNaughton, 2000; Boureau and
Dayan, 2011; Cools et al., 2011). Dopamine (DA) is believed to
enable or enhance the generation of active motivated behavior
(Berridge and Robinson, 1998; Niv et al., 2007; Salamone et al.,
2007; Beierholm et al., 2013) and to support instrumental learn-
ing (Frank et al., 2004; Daw and Doya, 2006;Wickens et al., 2007).
It has been observed that DA depletion leads to decreased motor
activity and decreased motivated behavior (Ungerstedt, 1971;
Palmiter, 2008), along with decreased vigor ormotivation to work
for rewards in demanding reinforcement schedules (Salamone
et al., 2005; Niv et al., 2007). Conversely, boosting DA levels
with levodopa invigorates motor responses in healthy humans
(Guitart-Masip et al., 2012a) and DA promotes “go” and impairs
“no-go” learning, for example in patients with Parkinson’s disease
(Frank et al., 2004). However, contrary to the expectations sug-
gested by this evidence, administration of levodopa reduced the
learning disadvantage of the no-go to win condition when com-
pared to the no-go to avoid losing (Guitart-Masip et al., 2013).
These effects suggested that DA is involved in decreasing the cou-
pling between action and valence, supposedly via DA’s actions
on neural functions implemented in prefrontal cortex (Hitchcott
et al., 2007). It is therefore unclear how striatal DA modulates the
coupling between action and valence uncovered in this task.
The aim of the present study was to test whether natu-
rally occurring differences in healthy humans in this valenced
action/inhibition learning might arise from dopaminergic mech-
anisms and how striatal DA effects the action/valence interaction.
To address this issue, we used the valenced go/no-go learning
paradigm in a cohort of young, healthy subjects, and tested them
for the TaqIA restriction length polymorphism (rs1800497), a
common genetic variation of the dopamine D2 receptor (DRD2)
gene known to affect D2 receptor expression and striatal DA
metabolism. Although the underlying molecular mechanisms are
yet not fully understood, the TaqIA polymorphism has been
repeatedly associated with reduced striatal DRD2 density in A1
carriers as evident from three post mortem studies (Noble et al.,
1991; Thompson et al., 1997; Ritchie and Noble, 2003) and two
out of three conducted in vivo binding studies (Laruelle et al.,
1998; Pohjalainen et al., 1998; Jonsson et al., 1999). Laakso et al.
(2005) suggested that the lower D2 receptor expression leads
to decreased autoreceptor function, thereby increasing the DA
and/or trace amine synthesis rate in the brains of A1 allele carri-
ers. Moreover, Kirsch et al. (2006) observed an increase of striatal
BOLD signal in response to the dopamine D2 receptor agonist
bromocriptine in subjects carrying the A1 allele, but not in sub-
jects without the A1 allele, and Stelzel et al. (2010) reported a
generally increased striatal BOLD signal in A1 carriers. As stri-
atal BOLD signal has been shown to correlate with DA release
(Schott et al., 2008), the increased striatal activation in A1 carri-
ers might be related to higher presynaptic dopaminergic activity
(Richter et al., 2013). Because striatal DA is associated with link-
ing action with reward (Berridge and Robinson, 1998; Frank et al.,
2004; Daw and Doya, 2006; Niv et al., 2007; Salamone et al., 2007;
Wickens et al., 2007; Beierholm et al., 2013), we hypothesized that
A1 carriers might show increased coupling between action and
valence.
MATERIALS AND METHODS
PARTICIPANTS
Participants were recruited from a cohort of 719 young healthy
volunteers of Caucasian ethnicity of a large-scale behavioral
genetic study conducted at the Leibniz Institute for Neurobiology,
Magdeburg. Given our hypothesis regarding differential perfor-
mance in the valenced go/no-go task as a function of striatal
D2 receptor availability, we selected participants a priori as a
function of DRD2 TaqIA genotype. To control for confounding
effects of genetic influences on prefrontal DA availability, we also
ensured a balanced distribution of the COMT Val108/158 Met
polymorphism that is known to affect prefrontal DA levels and
D1 receptor binding (Gogos et al., 1998; Matsumoto et al., 2003;
Meyer-Lindenberg et al., 2005; Slifstein et al., 2008). All partici-
pants were right-handed according to self-report, not genetically
related, and had obtained at least a university entrance diploma
(Abitur) as educational certificate. Importantly, all participants
had undergone routine clinical interview to exclude present or
past neurological or psychiatric illness, alcohol, or drug abuse,
use of centrally acting medication, the presence of psychosis or
bipolar disorder in a first-degree relative, and additionally, given
the design of the experiment, regular gambling. Two indepen-
dent cohorts of healthy participants were tested (cohort 1: 43
females and 44 males; age: range 19–36 years, mean 24.6 years,
SD = 3.1 years; cohort 2: 48 females and 47 males; age: range
20–33 years, mean 24.6 years, SD = 2.8 years). Because of a previ-
ously reported potential association of the A1 allele with nicotine
consumption (Verde et al., 2011; for reviews see Comings and
Blum, 2000; Lerman et al., 2007), smoking status was assessed
from the participants. All participants gave written informed con-
sent in accordance with the Declaration of Helsinki and received
financial compensation for participation. The work was approved
by the Ethics Committee of the University of Magdeburg, Faculty
of Medicine.
GENOTYPING
The DRD2/ANKK1 TaqIA restriction length polymorphism
(NCBI accession number: rs1800497) was genotyped using a pro-
tocol previously described in Richter et al. (2013). Genomic DNA
was extracted from blood leukocytes using the GeneMole® auto-
mated system (Mole Genetics AS, Lysaker, Norway) according to
the manufacturer’s protocol. Genotyping was performed using
PCR followed by allele-specific restriction analysis using previ-
ously described primers (Grandy et al., 1989). Genotyping was
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also performed for several additional polymorphisms, including
COMT Val108/158 Met (see Table 1), to control for confound-
ing effects of other genetic variants and to reduce the risk of
population stratification.
PARADIGM
We used a previously employed go/no-go learning task with
orthogonalized action requirements and outcome valence
(Guitart-Masip et al., 2012b, 2013; Chowdhury et al., 2013). The
trial timing is displayed in Figure 1. Each trial consisted of presen-
tation of a fractal cue, a target detection task, and a probabilistic
outcome. First, one out of four abstract fractal cues was displayed
for 1000ms. Participants were informed that a fractal indicated
whether they would subsequently be required to perform a tar-
get detection task by pressing a button (go) or not (no-go) and
that the cue also indicated the possible valence of the outcome
of the subjects’ behavior (reward/no reward or punishment/no
punishment). However, subjects were not instructed about the
contingencies for each fractal image and had to learn them by
trial and error. Themeaning of the fractal images was randomized
across participants. Following a variable interval (250–3500ms)
after offset of the fractal image, the target detection task started:
participants had the opportunity to press a button within a time
limit of 2000ms to indicate the side of a circle for go trials, or not
to press for no-go trials. After the offset of the circle after 1500
and 1000ms of fixation, subjects were presented with the out-
come. The outcome remained on screen for 2000ms and after a
variable intertrial interval (ITI; 750–1500ms) a new trial started.
Participants were informed that the outcome was probabilistic: in
win trials 80% of correct choices and 20% of incorrect choices
were rewarded with 0.50 C (the remaining 20% of correct and
80% of incorrect choices leading to no outcome), while in avoid
losing trials 80% of correct choices and 20% of incorrect choices
avoided a loss of 0.50 C (the remaining 20% of correct and 80% of
incorrect choices leading to a punishment). Thus, there were four
trial types depending on the nature of the fractal cue presented
at the beginning of the trial: press the correct button in the target
detection task to gain a reward (go to win); press the correct but-
ton in the target detection task to avoid punishment (go to avoid
losing); do not press a button in the target detection task to gain
a reward (no-go to win); do not press a button in the target detec-
tion task to avoid punishment (no-go to avoid losing). The task
included 240 trials, 60 trials per condition and was divided into
four sessions 9min each (15 trials per condition in randomized
order). Subjects were told that they would be paid their earnings
of the task up to a total of 25 C and a minimum of 7 C. Before
starting with the learning task, subjects performed 10 trials of the
target detection task in order to get familiarized with the speed
requirements.
STATISTICAL ANALYSIS
The percentage of correct choices in the target detection task
(correct button press for go conditions and correct omission of
responses in no-go trials) was collapsed across time bins of 30
trials per condition and analyzed with a mixed ANOVA with
time (1st/2nd half), action (go/no-go), and valence (win/lose)
as within-subject factors and TaqIA genotype (A1+/A1−) as
between-subject factor. Additionally reaction times of correct
Table 1 | Genotyped polymorphisms.
Polymorphism/Gene NCBI accession number Genotyping protocol
DRD2/ANKK1 TaqIA rs1800497 Richter et al., 2013
Primers for PCR:
5′-CCGTCGACGGCTGGCCAAGTTGTCTA-3′
5′-CCGTCGACCCTTCCTGAGTGTCATCA-3′
Restriction enzyme: TaqI
COMT Val108/158 Met rs4680 Schott et al., 2006; Wimber et al., 2011
Primers for PCR:
5′-ATGGCCCGCCTGCTGTCACCAG-3′
5′-TCTGACAACGGGTCAGGCACGCACAC-3′
Restriction enzyme: Hin1ll (NlaIII)
DAT1VNTR rs28363170 Schott et al., 2006
Primers for PCR:
5′-TGTGGTGTAGGAAACGGCCTGAG-3′
5′-CTTCCTGGAGGTCACGGCTCAAAGG-3′
PCR products were not digested
DRD2 C957T rs6277 Kompetitive allele-specific PCR (KASP)
Assay on Demand (LGC Genomics, Berlin,
Germany)
DARPP-32 rs907094 Primers for PCR:
5′-GCACCCCATGGAGCGAGAAGACAG-3′
5′-CGCATTGCTGAGTCTCACCTGCAGTC-3′
Restriction enzyme: Tru1l
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FIGURE 1 | Experimentalparadigmof theprobabilisticmonetarygo/no-go
task. Fractal images indicate the combination between action (go or no-go) and
valence (reward or loss). On go trials, subjects press a button for the side of a
circle.Onno-go trials theywithhold a response.Arrows indicate rewards (green)
or losses (red). Horizontal bars (yellow) symbolize the absence of awin or a loss.
The schematics at the bottom represent for each trial type the nomenclature
(left), the possible outcomes and their probabilities after response to the target
(“go”; middle), and the possible outcomes and their probability after
withholding a response to the target (“no-go”; right). gw, go to win; gal, go to
avoid losing; ngw, no-go towin; ngal, no-go to avoid losing; ITI, intertrial interval.
go responses (RTs) were analyzed using a mixed ANOVA with
valence (win/lose) and TaqIA genotype (A1+/A1−) as factors.
When appropriate, paired t-test, independent sample t-test or
Mann-Whitney U-test were used as post-hoc tests.
The analysis of the behavioral data was done in two stages.
In cohort 1 we included the TaqIA and the COMT Val108/158
Met polymorphism as between-subject factors. In the second we
specifically aimed to replicate the significant effect of TaqIA. The
following statistics include TaqIA as the only between-subject
factor.
RESULTS
GENOTYPING
Genotyping was performed in the entire cohort of 719 subjects,
and two sub-cohorts were recruited based on the DRD2/ANKK1
TaqIA genotype. The data of 87 participants in cohort 1 and 95
participants in cohort 2 were analyzed. In cohort 1, we identified
4 A1 homozygotes, 33 heterozygotes and 50 A2 homozygotes. In
cohort 2, genotyping revealed 4 A1 homozygotes, 30 heterozy-
gotes and 61 A2 homozygotes. The distributions in both groups
were at Hardy-Weinberg equilibrium (cohort 1: χ2 = 0.24,
p = 0.621; cohort 2: χ2 = 0.02, p = 0.898). A1 carriers (A1+:
A1/A1 and A1/A2) were grouped together for all subsequent anal-
yses as in previous behavioral and imaging studies of the TaqIA
polymorphism (Stelzel et al., 2010; Richter et al., 2013). The
groups A1+ and A1− (A2/A2) did not differ in gender, in age
or in the number of smokers and nonsmokers (Table 2).
To control for effects of prefrontal DA availability, participants
were also selected regarding the COMT Val108/158 Met (NCBI
accession number: rs4680) polymorphism. Genotyping revealed
31 Met/Met, 29Val/Met, and 27Val/Val carriers in cohort 1 and
30 Met/Met, 41Val/Met, and 24Val/Val carriers in cohort 2.
Allelic distribution for the COMT Val108/158 Met polymor-
phism did not differ significantly for either TaqIA A1 carriers or
A2 homozygotes (Table 2). The experimenters who performed
the behavioral task were blinded regarding DRD2/ANKK1 and
COMT genotypes.
To further control for effects of population stratification and
potential effects of putatively functional genetic variations in
the dopamine system, genotyping was also performed for the
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Table 2 | Demographic data.
A1+ A1−
COHORT 1
Women/Men (n = 87) 17/20 26/24 χ2 = 0.31, p = 0.577
Mean age (n = 87) 24.9 ± 3.6 24.3 ± 2.6 t(85) = 0.83, p = 0.410
Smokers/Nonsmokers (n = 87) 15/22 14/36 χ2 = 1.51, p = 0.220
COMT mm/vm/vv (n = 87) 13/14/10 18/15/17 χ2 = 0.73, p = 0.694
DAT1-VNTR 9+/9− (n = 85) 11/25 15/34 χ2 < 0.01, p = 0.996
C957T CC/CT/TT (n = 87) 11/19/7 8/24/18 χ2 = 4.04, p = 0.132
DARPP-32 CC/CT/TT (n = 87) 20/15/2 29/19/2 χ2 = 0.19, p = 0.912
COHORT 2
Women/Men (n = 95) 13/21 35/26 χ2 = 3.20, p = 0.074
Mean age (n = 95) 25.2 ± 3.3 24.2 ± 2.4 t(93) = 1.58, p = 0.121
Smokers/Nonsmokers (n = 95) 5/29 14/47 χ2 = 0.93, p = 0.335
COMT mm/vm/vv (n = 95) 11/14/9 19/27/15 χ2 = 0.09, p = 0.957
DAT1-VNTR 9+/9− (n = 93) 17/17 32/27 χ2 = 0.16, p = 0.693
C957T CC/CT/TT (n = 95) 15/17/2 3/37/21 χ2 = 25.49, p < 0.001
DARPP-32 CC/CT/TT (n = 95) 15/16/3 41/20/0 χ2 = 0.8.53, p = 0.014
Gender distribution, age (means ± standard deviations), number of smokers and nonsmokers. Allelic distributions for following polymorphisms: COMT Val108/158
Met (mm, met homozygotes; vm, val/met heterozygotes; mm, met homozygotes), DAT1-VNTR (9+, carriers of the 9-repeat allele 9/9 and 9/10; 9−, 10-repeat
homozygous subjects 10/10), C957T (CC/CT/TT carriers) and DARPP-32 (CC/CT/TT carriers). A1+; carriers of the A1 allele. A1−; A2 homozygotes.
DAT1-VNTR (NCBI accession number: rs28363170), the C957T
polymorphism within the DRD2 gene (NCBI accession num-
ber: rs6277) and the DARPP-32 polymorphism (NCBI acces-
sion number: rs907094) (see Table 1). Allelic distributions for
the DAT1-VNTR polymorphism did not differ significantly for
either TaqIA A1 carriers or A2 homozygotes (Table 2). However,
because of differences for the C957T and the DARPP-32 polymor-
phism, we additionally calculated an ANCOVA including these
two polymorphisms as covariates (see below).
BEHAVIORAL RESULTS
We initially performed an omnibus mixed-design ANOVA to test
for effects of both DRD2/ANKK1 and COMT genotypes. There
was a significant four-fold interaction of DRD2/ANKK1 TaqIA
with action, time and valence [F(1,81) = 5.11, p = 0.027], but no
effect of COMT Val108/158 Met polymorphism (all p > 0.120).
All further analyses were therefore focused on the DRD2/ANKK1
TaqIA polymorphism. We computed as ANOVA for repeated
measures on the percentage of correct (optimal) choices with
action (go/no-go), valence (win/lose) and time (1st/2nd half)
as within-subject factors and genotype (A1+/A1−) as between-
subject factor. See Table 3 for statistics.
Our study reproduced a main effect of action [cohort 1:
F(1, 85) = 62.56, p < 0.001; cohort 2: F(1, 93) = 50.87, p < 0.001]
and an action by valence interaction [cohort 1: F(1, 85) = 44.41,
p < 0.001; cohort 2: F(1, 93) = 37.72, p < 0.001], as demon-
strated in previous studies (Guitart-Masip et al., 2012b, 2013;
Cavanagh et al., 2013; Chowdhury et al., 2013). Subjects showed
better performance in conditions requiring a go choice than in
trials requiring a no-go choice [cohort 1: t(86) = 7.97, p < 0.001;
cohort 2: t(94) = 7.68, p < 0.001], and while they were better
at learning from reward as compared to punishment in the go
condition [cohort 1: t(86) = 6.28, p < 0.001; cohort 2: t(94) =
5.74, p < 0.001], this relation reversed in the no-go condition
[cohort 1: t(86) = 4.99, p < 0.001; cohort 2: t(94) = 4.63, p <
0.001]. As Guitart-Masip et al. (2012b, 2013) we also observed a
main effect of time [cohort 1: F(1, 85) = 135.92, p < 0.001; cohort
2: F(1, 93) = 189.21, p =< 0.001] and additionally an action by
time interaction [cohort 1: F(1, 85) = 19.09, p < 0.001; cohort
2: F(1, 93) = 59.77, p < 0.001], indicating a preponderant initial
bias toward go responses [cohort 1: t(86) = 4.62, p < 0.001;
cohort 2: t(94) = 8.46, p < 0.001].
Most interestingly for the current study, we observed a four-
fold interaction of action by valence by time by genotype
[cohort 1: F(1, 85) = 5.24, p = 0.025; cohort 2: F(1, 93) = 4.59,
p = 0.035]. This effect was observed in the absence of an action
by valence by genotype effect (cohort 1: p = 0.811; cohort 2:
p = 0.087). While the genotype groups did not differ signifi-
cantly in their mean performance in the first and second time
bin in any condition (cohort 1: p > 0.143; cohort 2: p > 0.167),
they showed a different degree of improvement from the first
to the second time interval (learning gain: mean performance
2nd half—mean performance 1st half; see Figure 2). Performance
of the A2 homozygotes in the no-go to win condition showed
increased improvement from the first to the second half of the
experiment compared to the A1 carriers [cohort 1: t(85) = 2.78,
p = 0.007]. In the second cohort this result was replicated [cohort
2: t(93) = 2.16, p = 0.033], and A1 carriers showed lower perfor-
mance in the go to avoid losing condition [cohort 2: t(93) = 2.26,
p = 0.026]. Because performance in the no-go to win condition
during early trials differed between the two cohorts, we tested
whether the observed interaction, which would likely reflect a
difference in learning rate, remained significant when combin-
ing both datasets. A Three-Way ANCOVA across both cohorts
(including cohort as a covariate of no interest; see Figure 2)
revealed the same three-way interaction revealed by the analyses
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Table 3 | Statistics on percentage of correct responses.
Effects Cohort 1 Cohort 2
Action F(1, 85) = 62.56,
p < 0.001, η2 = 0.42
F(1, 93) = 50.87,
p < 0.001, η2 = 0.35
Go > no-go go: = 87 ± 12%
no-go: = 73 ± 21%
t(86) = 7.97, p < 0.001
go: = 91 ± 9%
no-go: = 79 ± 18%
t(94) = 7.68, p < 0.001
Time F(1, 85) = 135.92,
p < 0.001, η2 = 0.62
F(1, 93) = 189.21,
p =< 0.001, η2 = 0.67
2nd half > 1st half 1st half: = 74 ± 15%
2nd half: = 86 ± 16%
t(86) = 11.89, p < 0.001
1st half: = 78 ± 13%
2nd half: = 92 ± 13%
t(94) = 14.68,
p < 0.001
Action × valence F(1, 85) = 44.41,
p < 0.001, η2 = 0.34
F(1, 93) = 37.72,
p < 0.001, η2 = 0.29
Go to win > go to
avoid losing
gw: = 91 ± 14%
gal: = 82 ± 14%
t(86) = 6.28, p < 0.001
gw: = 95 ± 12%
gal: = 87 ± 10%
t(94) = 5.74, p < 0.001
No-go to avoid losing
> no-go to win
ngw: = 66 ± 32%
ngal: = 81 ± 16%
t(86) = 4.99, p < 0.001
ngw: = 73 ± 30%
ngal: = 86 ± 11%
t(94) = 4.63, p < 0.001
Action × time F(1, 85) = 19.09,
p < 0.001, η2 = 0.18
F(1, 93) = 59.77,
p < 0.001, η2 = 0.39
1st half(go—no-go)
> 2nd
half(go—no-go)
1st half: = 17 ± 17%
2nd half: = 9 ± 18%
t(86) = 4.62, p < 0.001
1st half: = 18 ± 17%
2nd half: = 6 ± 16%
t(94) = 8.46, p < 0.001
Action × valence ×
time × genotype
F(1, 85) = 5.24,
p = 0.025, η2 = 0.06
F(1, 93) = 4.59,
p = 0.035, η2 = 0.05
A1−(ngw(2nd—1st
half)) >
A1+(ngw(2nd—1st
half))
A1+: = 8 ± 21%
A1−: = 22 ± 26%
t(85) = 2.78, p = 0.007
A1+: = 15 ± 22%
A1−: = 25 ± 24%
t(93) = 2.16, p = 0.033
Means ± standard deviations are shown. Only effects that were significant
in both cohorts are reported. ANOVA was computed with percent correct
responses as dependent variable and action, valence, time and genotype as
independent variables. Paired t-tests and t-tests for independent samples were
performed as post-hoc tests. gw, go to win; gal, go to avoid losing; ngw, no-
go to win; ngal, no-go to avoid losing. A1+; carriers of the A1 allele. A1−; A2
homozygotes.
in the separate cohorts [F(1, 179) = 9.87, p = 0.002]. Only in
one cohort there was a statistically significant three-way inter-
action [action by valence by time; cohort 1: F(1, 85) = 0.42, p =
0.517; cohort 2: F(1, 93) = 10.98, p = 0.001] and a time by geno-
type interaction [cohort 1: F(1, 85) = 3.77, p = 0.055; cohort 2:
F(1, 93) = 6.31, p = 0.014].
Statistics regarding reaction times (RTs) of the go responses are
summarized in Table 4. We computed an ANOVA with valence
(win/lose) as within-subject factor and genotype as between-
subject factor. Irrespective of genotype, RTs in the go to win
condition were shorter than in the go to avoid losing condition
[cohort 1: F(1, 85) = 14.06, p < 0.001; cohort 2: F(1, 93) = 11.21,
p = 0.001]. Regarding DRD2/ANKK1 TaqIA genotype, there was
only a trendwise interaction with valence [F(1, 93) = 3.38, p =
0.069] and a trend for a main effect [F(1, 93) = 3.67, p = 0.058]
in cohort 2, with the A1 carriers being slower in avoiding pun-
ishment as compared to the A2 homozygotes [t(93) = 2.04, p =
0.046]. Although this nominal effect together with the worse
accuracy of the A1 carriers in the go to avoid losing condition
(Figure 2) hints at a worse performance of the A1 carriers in this
condition, the interpretation of this result warrants caution as the
effects were only apparent in cohort 2 and, moreover, participants
were explicitly instructed to respond accurately, while speed was
not emphasized.
To rule out that the genotype effects are not simply explained
by differences in target detection performance the percentage
of trials in which subjects responded incorrectly in the target
detection task (i.e., left when the target was on the right side
of the display or vice versa) was measured and did not differ
significantly between genotype groups (Mann-Whitney U-test:
cohort 1: A1+: M ± SD = 1± 3%, A1−: M ± SD = 1± 2%,
z = −0.334, p = 0.738; cohort 2: A1+:M ± SD = 1± 3%, A1−:
M ± SD = 0± 1%, z = −0.428, p = 0.668).
Because the TaqIA polymorphism is located downstream of
the DRD2 gene, the observed genotype effects might putatively
result from linkage disequilibrium with other DRD2 polymor-
phisms, including the C957T. We indeed observed an imbalanced
distribution of the C957T polymorphism (rs6277) among TaqIA
A1 carriers vs. A2 homozygotes numerically in the first cohort
(χ2 = 4.04, p = 0.132) and significantly in the second cohort
(χ2 = 25.49, p < 0.001). Moreover, the DARPP-32 polymor-
phism (rs907094) was unequally distributed in the second cohort
only (χ2 = 8.53, p = 0.014). In order to rule out confound-
ing effects, we included the polymorphisms as covariates in an
additional ANCOVA. The same was done for COMT Val108/158
Met (rs4680), because the cohorts were stratified with respect to
that polymorphism. Importantly, the four-fold action by valence
by time by genotype interaction for the TaqIA polymorphism
remained significant [cohort 1: F(1, 82) = 4.63, p = 0.034, cohort
2: F(1, 90) = 5.07, p = 0.027], while there was no effect for C957T
(cohort 1: p = 0.472, cohort 2: p = 0.810), DARPP-32 (cohort
1: p = 0.578, cohort 2: p = 0.148) or COMT Val108/158 Met
polymorphism (cohort 1: p = 0.161, cohort 2: p = 0.856).
DISCUSSION
The goal of this study was to investigate how a genetic vari-
ant linked to striatal DA responsivity affects the action/valence
interaction. To this end, two independent cohorts consisting
of 87 and 95 healthy participants were genotyped for the
well-characterized DRD2/ANKK1 TaqIA polymorphism (Grandy
et al., 1989; Dubertret et al., 2004; Neville et al., 2004) and per-
formed the previously described valenced go/no-go task (Guitart-
Masip et al., 2012b, 2013, 2014; Cavanagh et al., 2013; Chowdhury
et al., 2013). Our results show differential learning performance
in the carriers of the less common A1 allele of the TaqIA poly-
morphism, which has previously been linked to lower striatal
dopamine D2 receptor expression. Replicating previous results,
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FIGURE 2 | Effects of Taq1A genotype on choice performance in two
independent cohorts and in the entire sample (data of both cohorts
combined). Line charts at the left show mean values of correct
responses (±s.e.m.) in A1 carriers (red) and A2 homozygotes (blue) in
the first and the second half of trials for all four conditions. Bar plots at
the right show the differences between mean (±s.e.m.) values of correct
responses of second half of trials minus first half of trials in A1 carriers
(red) and A2 homozygotes (blue) for each condition. This score
represents the four-fold interaction of action by valence by time by
genotype. Compared to the A2 homozygotes carriers of the A1 allele
showed a diminished learning to withhold an action to receive a reward.
Post-hoc comparisons via t-test: ∗p < 0.05.
participants were, irrespective of genotype, more successful in
learning active choices in rewarded conditions and passive choices
in punished conditions, with response inhibition to obtain a
reward (no-go to win) being the condition most difficult to learn.
The DRD2 TaqIA polymorphism exerted a modulatory influence
on learning performance in the no-go to win condition with A1
carriers showing lower learning rates throughout the experiment.
It has to be emphasized that, despite the fact that in the present
study learning curves of the two cohorts differed to some extent
and initial performance of A1 carriers was not identical, we did
yet observe a replicable attenuation of learning rates in A1 carriers
that was specific to the no-go to win condition, and, importantly,
the effect was even more pronounced when combining both
datasets (using cohort as a covariate of no interest; see Figure 2).
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Table 4 | Statistics on reaction times of correct go responses.
A1+ A1−
COHORT 1
Go to win 527 ± 128ms 535 ± 88ms t(85) = −0.36, p = 0.719
Go to avoid losing 547 ± 129ms 564 ± 117ms t(85) = −0.65, p = 0.521
COHORT 2
Go to win 561 ± 100ms 534 ± 76ms t(93) = 1.48, p = 0.144
Go to avoid losing 583 ± 107ms 540 ± 76ms t(93) = 2.04, p = 0.046
Means ± standard deviations are shown. A1+; carriers of the A1 allele. A1−; A2
homozygotes.
It is important to note that there are two potential mechanisms
by which valence can disrupt the choice of appropriate actions
in the current task. The first mechanism is implemented at the
time of the choice and can be seen as “Pavlovian” mechanism
by which the anticipation of reward or punishment promotes
action or inhibition, respectively (Dayan et al., 2006; Huys et al.,
2011; Guitart-Masip et al., 2012b). The second mechanism is
implemented at the time of outcome and is related to the role
of DA within the striatum. According to a prevalent view in
reinforcement learning and decision making, DA neurons signal
reward prediction errors (Montague et al., 1996; Schultz et al.,
1997; Bayer and Glimcher, 2005), in the form of phasic bursts
for positive prediction errors and dips below baseline firing rate
for negative prediction errors (Bayer et al., 2007), resulting in
corresponding peaks and dips of dopamine availability in tar-
get structures, most prominently the striatum (McClure et al.,
2003; O’Doherty et al., 2003, 2004; Pessiglione et al., 2006). In the
striatum, increases of DA in response to an unexpected reward
reinforce the direct pathway via activation of D1 receptors and
thereby facilitate the future generation of go choices under similar
circumstances, while dips in DA levels in response to an unex-
pected punishment reinforce the indirect pathway via reduced
activation of D2 receptors and thus facilitate the subsequent gen-
eration of no-go choices in comparable situations (Frank et al.,
2004, 2007; Wickens et al., 2007; Hikida et al., 2010; see Figure 3).
The effects related to the TaqIA polymorphism observed in
the present study apparently reflect changes in the learning pro-
cess, thus likely pointing to the function of DA in the ability to
flexibly learn go or no-go choices based on the outcomes pro-
duced by previous actions. Our results are in apparent contrast
to the effects previously reported in the same task after admin-
istration of levodopa. In that study, boosting DA levels resulted
in a decoupling between action and valence that did not reflect
any changes in the rate of learning (Guitart-Masip et al., 2013).
Instead, the effects observed in that study boosted the asymp-
tote reached by the participants that received levodopa. Using
computational modeling, that effect was best characterized as a
decreased influence of a Pavlovian control mechanism over the
instrumental control mechanisms attempting to learn the task
(Guitart-Masip et al., 2013). Similarly, in older adults, struc-
tural MRI measures of substantia nigra/ventral tegmental area
(SN/VTA) integrity have also been linked to improved learning
and a lower action bias (Chowdhury et al., 2013). One proposed
explanation for the reduced coupling between action and valence
in conditions associated with increased DA availability has been
a likely increase of dopaminergic activity in the prefrontal cortex
where DA influences the balance between different control mech-
anisms (Hitchcott et al., 2007). The implication of a prefrontal
mechanism decreasing the Pavlovian influences on behavior and
supporting performance of the no-go to win condition in this task
has been shown in fMRI (Guitart-Masip et al., 2012b) and EEG
experiments (Cavanagh et al., 2013). It should be noted, though,
that, in the present study, we did not observe any behavioral
differences as a function of the COMT Val108/158 Met polymor-
phism, which has previously been linked to prefrontal dopamine
availability (Meyer-Lindenberg et al., 2005).
Receptor binding studies in vitro and in vivo have shown that
A1 carriers show lower striatal D2 receptor expression (Noble
et al., 1991; Thompson et al., 1997; Pohjalainen et al., 1998;
Jonsson et al., 1999; Ritchie and Noble, 2003). On the other hand,
A1 carriers also exhibit increased striatal DA synthesis, possibly
as a result of reduced autoinhibitory signaling from presynaptic
D2-type autoreceptors (Laakso et al., 2005). Previous behavioral
and neuroimaging studies have in fact yielded results that would
be best explained by parallel reduction of striatal postsynaptic
D2 receptors and increased presynaptic dopaminergic activity in
A1 carriers, with the latter also resulting in increased DA avail-
ability both in the striatum and in extrastriatal regions (Kirsch
et al., 2006; Stelzel et al., 2010; Richter et al., 2013). According
to those observations, A1 carriers would be assumed to show a
less pronounced decrease of dopaminergic signaling after neg-
ative prediction errors in the indirect pathway and a shift to a
more action-oriented behavioral pattern mediated by the direct
pathway (Figure 3). Such a pattern bears some resemblance to the
concept of behavioral impulsivity (Tomie et al., 1998; Flagel et al.,
2010, 2011), and it is noteworthy in this context that the A1 allele
has been linked to risk for impulsivity-related psychiatric disor-
ders, most prominently alcohol dependence (Noble et al., 1991;
Comings et al., 1996; Noble, 2003; Eisenberg et al., 2007; Wang
et al., 2013). However, this does not explain, why A1 carriers
exhibit a relatively specific performance disadvantage in the no-go
to win, but not in the no-go to avoid losing condition. One possible
reason would be that a punishment instead of a neutral feed-
back in the no-go to avoid losing condition might lead to a higher
prediction error as compared to a neutral feedback instead of a
reward in the no-go to win condition. Another reason might be
that, for example, serotonin plays a specific role in punishment-
related behavior (Daw et al., 2002; Boureau and Dayan, 2011;
Cools et al., 2011; Guitart-Masip et al., 2012b, 2013; Den Ouden
et al., 2013) and thus further modulates the performance in the
no-go to avoid losing condition.
The investigation of modulators of stereotyped hard-wired
behavioral responses is of interest to clinicians as it may help
to develop novel treatment approaches for neurological or psy-
chiatric disorders. The TaqIA polymorphism is one of the most
extensively studied genetic variations in neuropsychiatric disor-
ders with presumed dopaminergic dysfunction, and studies have
pointed to a potential pleiotropic effect with A1 allele carriers
showing an increased risk for addiction, but a lower risk for
schizophrenia (e.g., Comings et al., 1996; Noble, 2003; Dubertret
et al., 2004; Wang et al., 2013; Zhang et al., 2014). Moreover,
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FIGURE 3 | A model of the putative influence of the TaqIA
polymorphism on action-valence interaction. DA neurons signal reward
prediction errors in the form of phasic bursts for positive prediction
errors and dips below baseline firing rate for negative prediction errors.
Increases of DA in response to an unexpected reward reinforce the
direct pathway via activation of D1 receptors and thereby facilitate the
future generation of go choices under similar circumstances, while dips
in DA levels in response to an unexpected punishment reinforce the
indirect pathway via reduced activation of D2 receptors and thus facilitate
the subsequent generation of no-go choices in comparable situations. A1
carriers have less D2 receptors and thus would be assumed to have less
limitation of dopaminergic signaling after negative prediction errors in the
indirect pathway and a shift to a more action-oriented behavioral pattern
mediated by the direct pathway.
studies in healthy humans have suggested a role of the TaqIA
A1 variant in approach-related personality traits (Noble et al.,
1998; Reuter et al., 2006; Lee et al., 2007; Smillie et al., 2010) and
on motivated interference processing (Richter et al., 2013). The
relation between the single nucleotide polymorphism (SNP) and
instrumental learning has also been investigated. Previous studies
have shown an impairment of the carriers of the A1 allele in no-go
learning to avoid behaviors that yield negative outcomes (Klein
et al., 2007; Frank and Hutchison, 2009; Jocham et al., 2009).
However, those studies have only used conditions in which par-
ticipants had to approach a reward or avoid a punishment. Since
the interaction between action and valence has a pivotal influence
on instrumental learning (Guitart-Masip et al., 2012b), such stud-
ies could not provide information on possible action by valence
interactions, and the use of the valenced go/no-go-learning task
with orthogonalized action and valence enables a more precise
investigation of the contribution of the dopaminergic system in
behavioral adaptation.
The TaqIA polymorphism, initially identified to be located on
the DRD2 gene on human chromosome 11q22–23 (Grandy et al.,
1989), is located 10kb downstream of the DRD2 termination
codon on 11q23.1, within coding region of the adjacent ankyrin
repeat and kinase domain containing 1 (ANKK1) gene (Dubertret
et al., 2004; Neville et al., 2004). Because the DRD2 and ANKK1
genes are closely linked (Neville et al., 2004; Ponce et al., 2009),
it has been proposed that genetic variations in linkage disequi-
librium (LD) with the SNP might explain the observed relation-
ship between the TaqIA and alterations of human dopaminergic
neurotransmission. The SNP is indeed in LD with several poly-
morphisms on the DRD2 gene (Duan et al., 2003; Ritchie and
Noble, 2003; Fossella et al., 2006) and one of them is the C957T
polymorphism (rs6277) for which also modulations on instru-
mental learning have been observed (Frank et al., 2007, 2009;
Frank and Hutchison, 2009). However, its influence on dopamin-
ergic neurotransmission is not clear since in vivo and in vitro data
are in conflict (Duan et al., 2003; Hirvonen et al., 2004; see also
erratum byHirvonen et al., 2004, 2009a,b) and no association was
found between C957T and DA synthesis capacity in vivo (Laakso
et al., 2005) and C957T and D2 receptor mRNA expression in post
mortem brain tissue (Zhang et al., 2007). When controlling for a
potential influence of this SNP in our analysis, the effect of TaqIA
genotype was still significant. We cannot rule out, though, that
another variant in the DRD2 gene—or perhaps in the ANKK1
gene—linked to TaqIA might be responsible for the observed
genotype-related differences in learning rate.
In order to control for genetic influences of another genetic
variant known to affect prefrontal DA levels and thereby cor-
tical D1 receptor stimulation (Gogos et al., 1998; Matsumoto
et al., 2003; Meyer-Lindenberg et al., 2005; Slifstein et al., 2008)
we selected our participants to have comparable distributions
of the COMT Val108/158 Met genotype. Importantly, the allelic
distribution of COMT Val108/158 Met alleles did not differ
significantly between TaqIA A1 carriers and A2 homozygotes.
It must nevertheless be kept in mind that genetic variations
within the dopaminergic system do not exert their effects in
isolation. Frank et al. (2007), for example, observed multiple
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roles for DA in reinforcement learning when investigating effects
of the COMT Val108/158 Met, the DARPP-32, and the DRD2
C957T polymorphism on reward-based probabilistic learning.
Even though we controlled for these polymorphisms in our exper-
iment, we cannot completely rule out gene-gene interactions. Our
moderately large sample sizes allowed us to examine effects of
single genetic variants on behavioral outcomes, but the system-
atic analysis of gene-gene interactions would require substantially
larger cohorts. In addition to the likely polygenic contribution
of variants in the dopaminergic system to action by valence
interaction, also other neuromodulatory transmitters must be
considered in future studies.
CONCLUSION
Our findings provide further evidence for a potential genetic
basis of individual differences in probabilistic learning and,
more specifically, suggest that genetically mediated differences
in dopaminergic neuromodulation not only affect learning per
se, but also can specifically affect behavioral phenomena like a
Pavlovian action bias when a reward is expected. With respect to
future research directed at individual differences in learning, our
findings should thereby caution researchers to take into account
the non-orthogonal nature of action by valence interactions.
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